Wednesday, February 08, 2012
Penn State Hershey Cancer Institute researchers are trying to determine if selenium yeast and selenomethionine lower prostate-specific antigen levels and prevent other markers related to prostate cancer development in healthy individuals of different age groups. (more)
Wednesday, January 04, 2012
Prostate cancer strikes one in six American men. There's no better time than now to get checked for prostate cancer. Penn State Milton S. Hershey Medical Center will offer a free prostate cancer screening from 5:30 to 7:30 p.m. on Thursday, Jan. 12 in University Physician Center Suite 3100. Appointments are available on a first-call basis.
For more information and to register, call 1-800-243-1455. (more)
Tuesday, September 13, 2011
Prostate cancer is a significant public health concern and cause of morbidity among men in the United States. Current treatment alternatives for clinically localized prostate cancer include removal of the prostate gland, radiation to the cancerous prostate, active surveillance or other treatments (hormonal or cryotherapy). (more)
Wednesday, September 22, 2010
Prostate cancer develops in the glandular tissue of the male prostate, a reproductive gland situated below the bladder and in front of the rectum. The urinary sphincter (muscle that controls the flow of urine) is situated just below the prostate gland, and the nerves which allow a man to have an erection run on either side of the prostate. The prostate produces part of the fluid in semen. After diagnosis, the management of localized prostate cancer (cancer which has not spread or metastasized to other parts of the body) may be divided into three general categories: surgery, radiation therapy or active surveillance. (more)
Wednesday, September 08, 2010
Penn State Hershey Cancer Institute and Penn State Hershey Urology, Penn State Milton S. Hershey Medical Center are offering free prostate cancer screenings as part of Prostate Cancer Awareness Month in September. (more)
Wednesday, September 01, 2010
Prostate cancer is a significant public health concern and cause of morbidity among American men. It is the most commonly diagnosed cancer in the United States (excluding skin cancers) and is second only to lung cancer as a contributor to cancer deaths in American men. In 2010, it is estimated that nearly 218,000 new cases will be diagnosed and more than 32,000 men will die of prostate cancer. The lifetime probability of developing prostate cancer is one in six for American males. Screening can detect prostate cancer in its earliest stages when it is asymptomatic, or when signs and symptoms aren't present, and has the potential to decrease both morbidity and mortality. (more)
Wednesday, August 18, 2010
One in six men is at risk of getting prostate cancer in their lifetime. Penn State Hershey Cancer Institute researchers are trying to determine if selenium yeast and selenomethionine lower prostate-specific antigen levels and prevent other markers related to prostate cancer development in healthy individuals of different age groups. Selenium is a mineral and is known to protect against cancer in laboratory animal models. (more)
Tuesday, September 22, 2009
Prostate cancer is the most commonly diagnosed cancer in the United States (excluding skin cancers) and is second only to lung cancer as a contributor to cancer deaths in American men. In 2009, it is estimated that 192,280 new cases will be diagnosed and more than 27,000 men will die of prostate cancer. The lifetime probability of developing prostate cancer is one in six for American men. Current treatment alternatives for clinically localized prostate cancer include removal of the prostate gland (surgery), radiation to the cancerous prostate (external beam or radioactive seed implants), active surveillance, or other treatments (hormonal or cryotherapy). Robotic surgery represents the next potential iteration for advances in minimally invasive surgery, according to this week's edition of The Medical Minute, a service of the Penn State Milton S. Hershey Medical Center. (more)
Wednesday, September 02, 2009
Penn State Hershey Cancer Institute and Penn State Hershey Urology, Penn State Milton S. Hershey Medical Center are offering free prostate cancer screenings and educational programs as part of Prostate Cancer Awareness Month in September. (more)